Celanese completes sale of another 19% of Nutrinova JV to Mitsui

Key highlights
  • Celanese received $152 million in cash for the additional 19% stake in the Nutrinova food ingredients joint venture.
  • Celanese retains an 11% interest in Nutrinova.
  • Celanese plans to use the proceeds for deleveraging and is targeting $1 billion in divestiture proceeds by the end of 2027.
  • Celanese will temporarily own and operate a diketene facility in Frankfurt before transferring it to Nutrinova; Nutrinova will bear all associated costs, including the purchase price.

Transaction and proceeds

Celanese completed the sale of an additional 19% of its Nutrinova food ingredients joint venture to Mitsui & Co. for $152 million in cash. Celanese retains an 11% interest in the business. The divested stake represented approximately $4 million of equity earnings in 2025.

Celanese plans to use the proceeds for continuing deleveraging. The sale also advances its target of generating $1 billion in divestiture proceeds by the end of 2027.

Diketene facility

Celanese has agreed to temporarily own and operate a diketene facility at its Frankfurt chemical park to secure raw material supply for Nutrinova. Ownership of the facility will later transfer to Nutrinova, which will bear all costs of ownership and operation, including the purchase price.

Source: Celanese

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

2 November 2026
Celanese Q3 2026 earnings beat and raises full-year outlook

Q3 adjusted EPS $1.65 on $2.6B sales (+6% y/y); Q3 free cash flow $461M; raised full‑year adjusted EPS to $6.00–6.25 and FCF outlook to $750–800M.

31 August 2026
Celanese sells additional 19% stake in Nutrinova JV to Mitsui

Transaction yields roughly $152 million cash; seller retains 11% and will operate a diketene unit in transition; expected close in Q4.